--2025/Q2-- / 0.000--
--2025/Q1-- / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Ally Financial
ALLY
5
Louisiana-Pacific
LPX
CA Stock MarketDetailed Quotes
NGEN NervGen Pharma Corp
- 3.560
- +0.020+0.56%
15min DelayTrading May 12 09:44 ET
252.72MMarket Cap-9.89P/E (TTM)
3.630High3.560Low10.80KVolume3.620Open3.540Pre Close39.00KTurnover3.75052wk High0.02%Turnover Ratio70.99MShares1.65052wk Low-0.36EPS TTM210.06MFloat Cap3.980Historical HighLossP/E (Static)59.01MShs Float0.800Historical Low-0.36EPS LYR1.98%Amplitude--Dividend TTM98.89P/B1Lot Size--Div YieldTTM
NervGen Pharma Corp Key Stats
NervGen Pharma Corp Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: CAD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
NervGen Pharma Corp Earnings Reports
Read more
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting